Effects of heat/citric acid reprocessing on high-flux polysulfone dialyzers.

The surface features, morphology, and tensile properties of fibers obtained from pristine, reprocessed, and reused Fresenius Polysulfone High-Flux (Hemoflow F80A) hemodialyzers have been studied. Scanning electron microscopy of the dialyzer fibers revealed a dense skin layer on the inner surface of the membrane and a relatively thick porous layer on the outer surface. Transmission electron microscopy and atomic force microscopy showed an alteration in membrane morphology due to reprocessing and reuse, or to a deposition of blood-borne material on the membrane that is not removed with reprocessing. Fluorescent microscopy images also showed that a fluorescent material not removed by heat/citric acid reprocessing builds up with continued use of the dialyzers. The tensile properties of the dialyzer fibers were not affected by the heat/citric acid reprocessing procedure. The protein layers formed on pristine and reused hemodialyzer membranes during clinical use were also studied using sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotting. A considerable amount of protein was found on the blood side of single and multiple use dialyzers. Proteins adsorbed on the dialysate side of the membrane were predominantly in the molecular weight region below 30 kDa. Little protein was detected on the membranes of reprocessed hemodialyzers.

In vitro and in vivo evaluation of an oscillometric device for monitoring blood pressure in dialysis patients.

BACKGROUND: Nowadays, an increasing number of dialysis machines lodge a blood pressure (BP) measuring device, whose accuracy has a clear implication for the patients' clinical management. METHODS: An automated oscillometric sphygmomanometer (HD-BPM by Gambro Dasco) used during haemodialysis was submitted to both in vitro and in vivo tests, in order to evaluate some modifications aimed at improving measurement accuracy and consistency. The results were compared with those obtained by another oscillometric monitor (BX-100 by Colin). Three steps of evaluation were followed. First, the maintenance of the overall accuracy requirements prescribed by ANSI/AAMI SP-10 standard was verified. Then, an in vitro validation was carried out by using a test simulator. Finally, during a multi-centre field trial, 392 BP measurement sessions on 53 dialysis patients were collected. Every session consisted of two consecutive intra-dialysis measurements by the oscillometric monitors, each one performed simultaneously to an auscultatory measurement. A comparison with the intra-arterial method was performed as well. RESULTS: When compared with an in vivo data set previously collected, the HD-BPM accuracy complied with required limits. Second, the internal repeatability with respect to the simulator was satisfactory (SD of the differences between device and simulator readings: HD-BPM: systolic = 5.7, diastolic = 4.2; BX-100: systolic = 4.2, diastolic = 5.5 mmHg). Moreover, the comparison between oscillometric and auscultatory methods during in vivo trial gave similar results for the two monitors, even if systolic pressure SD exceeds the limit recommended by ANSI/AAMI SP-10 (mean value of the differences +/- SD: HD-BPM: systolic = 0.5 +/- 9.0, diastolic = 1.5 +/- 6.9; BX-100: systolic = 3.1 +/- 8.2, diastolic = -2.0 +/- 7.6 mmHg). CONCLUSIONS: These data underline the importance of performing accuracy evaluations for BP monitors in the conditions where they normally work, by using well-accepted protocols.